Corbus Pharmaceuticals (CRBP) Short Interest Ratio & Short Volume → New York goes dark, then America. (From Porter & Company) (Ad) Free CRBP Stock Alerts $39.24 +2.71 (+7.42%) (As of 04/19/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Corbus Pharmaceuticals Short Interest DataCurrent Short Volume475,600 sharesPrevious Short Volume403,800 sharesChange Vs. Previous Month+17.78%Dollar Volume Sold Short$18.66 millionShort Interest Ratio / Days to Cover0.5Last Record DateMarch 31, 2024Outstanding Shares10,510,000 sharesFloat Size10,380,000 sharesShort Percent of Float4.58%Today's Trading Volume283,601 sharesAverage Trading Volume808,364 sharesToday's Volume Vs. Average35% Short Selling Corbus Pharmaceuticals ? Sign up to receive the latest short interest report for Corbus Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCRBP Short Interest Over TimeCRBP Days to Cover Over TimeCRBP Percentage of Float Shorted Over Time Ad Crypto Swap ProfitsDid You Get Your Free Bitcoin Yet?And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here Corbus Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/2024475,600 shares $18.66 million +17.8%4.6%0.5 $39.24 3/15/2024403,800 shares $17.64 million +560.9%3.9%0.5 $43.68 2/29/202461,100 shares $1.89 million -34.2%0.6%0.1 $30.90 2/15/202492,900 shares $2.09 million -80.0%0.9%0.1 $22.48 1/31/2024464,700 shares $12.31 million +1,553.7%4.5%0.6 $26.49 1/15/202428,100 shares $166,633.00 -29.4%0.6%1.2 $5.93 Get the Latest News and Ratings for CRBP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Corbus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 12/31/202339,800 shares $240,392.00 -16.4%0.9%2.2 $6.04 12/15/202347,600 shares $261,800.00 +4.6%1.1%3.1 $5.50 11/30/202345,500 shares $304,395.00 -19.8%1.0%3.4 $6.69 11/15/202356,700 shares $255,717.00 +3.3%1.3%4.7 $4.51 10/31/202354,900 shares $299,205.00 -11.0%1.2%5.1 $5.45 10/15/202361,700 shares $372,051.00 -3.1%1.4%6.4 $6.03 9/30/202363,700 shares $429,338.00 -2.6%1.4%5.7 $6.74 9/15/202365,400 shares $459,108.00 -13.3%1.5%5.4 $7.02 8/31/202375,400 shares $550,420.00 -6.1%1.7%5.2 $7.30 8/15/202380,300 shares $514,723.00 -10.6%1.8%4.5 $6.41 7/31/202389,800 shares $646,560.00 -8.6%2.0%3.8 $7.20 7/15/202398,200 shares $753,194.00 -13.3%2.2%2.7 $7.67 6/30/2023113,300 shares $888,272.00 +0.2%2.6%2 $7.84 6/15/2023113,100 shares $876,525.00 +4.9%2.6%1.3 $7.75 5/31/2023107,800 shares $1.02 million -23.6%2.6%0.2 $9.47 5/15/2023141,100 shares $1.48 million -31.2%3.4%0.3 $10.50 4/30/2023205,100 shares $1.80 million -31.0%4.9%0.5 $8.78 4/15/2023297,200 shares $2.85 million -17.7%7.2%0.7 $9.59 3/31/2023360,900 shares $2.62 million +147.0%8.7%0.8 $7.27 3/15/2023146,100 shares $425,151.00 -1.8%3.5%0.4 $2.91 2/28/2023148,700 shares $444,613.00 +25.1%3.6%2 $2.99 2/15/2023118,900 shares $366,212.00 -96.0%2.9%0.8 $3.08 1/31/20232,960,000 shares $459,096.00 -5.4%2.4%0.7 $0.16 1/15/20233,130,000 shares $453,224.00 -15.0%2.5%0.7 $0.14 12/30/20223,680,000 shares $406,640.00 -20.7%3.0%0.7 $0.11 12/15/20224,640,000 shares $575,360.00 +17.8%3.7%0.9 $0.12 11/30/20223,940,000 shares $766,330.00 -15.1%3.2%0.8 $0.19 11/15/20224,640,000 shares $625,472.00 -2.5%3.7%1.9 $0.13 10/31/20224,760,000 shares $618,800.00 +22.1%3.8%1.9 $0.13 10/15/20223,900,000 shares $468,000.00 +4.8%3.1%1.6 $0.12 9/30/20223,720,000 shares $613,800.00 +10.7%3.0%3.6 $0.17 9/15/20223,360,000 shares $697,536.00 -11.6%2.7%3.6 $0.21 8/31/20223,800,000 shares $766,080.00 -1.6%3.1%4.5 $0.20 8/15/20223,860,000 shares $992,406.00 +18.4%3.1%4.4 $0.26The “Perfect Storm” for Gold (Ad)Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.Click here now to download the free Precious Metals Buying Guide! CRBP Short Interest - Frequently Asked Questions What is Corbus Pharmaceuticals' current short interest? Short interest is the volume of Corbus Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of March 31st, traders have sold 475,600 shares of CRBP short. 4.58% of Corbus Pharmaceuticals' shares are currently sold short. Learn More on Corbus Pharmaceuticals' current short interest. Which institutional investors are shorting Corbus Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Corbus Pharmaceuticals: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Corbus Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.58% of Corbus Pharmaceuticals' floating shares are currently sold short. Is Corbus Pharmaceuticals' short interest increasing or decreasing? Corbus Pharmaceuticals saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 475,600 shares, an increase of 17.8% from the previous total of 403,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Corbus Pharmaceuticals' float size? Corbus Pharmaceuticals currently has issued a total of 10,510,000 shares. Some of Corbus Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Corbus Pharmaceuticals currently has a public float of 10,380,000 shares. How does Corbus Pharmaceuticals' short interest compare to its competitors? 4.58% of Corbus Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Corbus Pharmaceuticals: Shattuck Labs, Inc. (4.40%), Harpoon Therapeutics, Inc. (4.31%), Solid Biosciences Inc. (3.05%), Celcuity Inc. (6.11%), Stoke Therapeutics, Inc. (15.01%), Cogent Biosciences, Inc. (11.34%), Wave Life Sciences Ltd. (2.94%), Acrivon Therapeutics, Inc. (4.43%), Merrimack Pharmaceuticals, Inc. (4.97%), Immutep Limited (1.43%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Corbus Pharmaceuticals stock? Short selling CRBP is an investing strategy that aims to generate trading profit from Corbus Pharmaceuticals as its price is falling. CRBP shares are trading up $2.71 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Corbus Pharmaceuticals? A short squeeze for Corbus Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CRBP, which in turn drives the price of the stock up even further. How often is Corbus Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CRBP, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: STTK Short Interest Data HARP Short Interest Data SLDB Short Interest Data CELC Short Interest Data STOK Short Interest Data COGT Short Interest Data WVE Short Interest Data ACRV Short Interest Data MACK Short Interest Data IMMP Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CRBP) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersBiden’s $374B Giveaway Into This SectorDTISHOCKING Crypto Leak…Crypto 101 MediaHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for 2024InvestorPlaceOptions trading has suddenly become more reliable.Eagle PublishingHow Biden has already won 2024Porter & CompanyTop 5 AI Stocks to Buy for 2024Market Moving TrendsUrgent alert: open this for a huge profit potentialTimothy Sykes